Should colorectal cancer screening be considered in elderly persons without previous screening?: A cost-effectiveness analysis
Background: The U.S. Preventive Services Task Force recommends against routine screening for colorectal cancer (CRC) in adequately screened persons older than 75 years but does not address the appropriateness of screening in elderly persons without previous screening. Objective: To determine at what...
| Main Authors: | Van Hees, F., Habbema, D., Meester, R., Lansdorp_Vogelaar, Iris, Van Ballegooijen, M., Zauber, A. |
|---|---|
| Format: | Journal Article |
| Published: |
2014
|
| Online Access: | http://hdl.handle.net/20.500.11937/49910 |
Similar Items
Personalizing Colonoscopy Screening for Elderly Individuals Based on Screening History, Cancer Risk, and Comorbidity Status Could Increase Cost Effectiveness
by: Van Hees, F., et al.
Published: (2015)
by: Van Hees, F., et al.
Published: (2015)
How much colonoscopy screening should be recommended to individuals with various degrees of family history of colorectal cancer?
by: Wilschut, J., et al.
Published: (2011)
by: Wilschut, J., et al.
Published: (2011)
Colorectal cancer deaths attributable to nonuse of screening in the United States
by: Meester, R., et al.
Published: (2015)
by: Meester, R., et al.
Published: (2015)
The value of models in informing resource allocation in colorectal cancer screening: The case of the Netherlands
by: Van Hees, F., et al.
Published: (2015)
by: Van Hees, F., et al.
Published: (2015)
Contribution of screening and survival differences to racial disparities in colorectal cancer rates
by: Lansdorp_Vogelaar, Iris, et al.
Published: (2012)
by: Lansdorp_Vogelaar, Iris, et al.
Published: (2012)
The appropriateness of more intensive colonoscopy screening than recommended in medicare beneficiaries: A modeling study
by: Van Hees, F., et al.
Published: (2014)
by: Van Hees, F., et al.
Published: (2014)
Cost-effectiveness of colorectal cancer screening
by: Lansdorp_Vogelaar, Iris, et al.
Published: (2011)
by: Lansdorp_Vogelaar, Iris, et al.
Published: (2011)
Clarifying differences in natural history between models of screening: The case of colorectal cancer
by: Van Ballegooijen, M., et al.
Published: (2011)
by: Van Ballegooijen, M., et al.
Published: (2011)
The impact of stratifying by family history in colorectal cancer screening programs
by: Goede, S., et al.
Published: (2015)
by: Goede, S., et al.
Published: (2015)
Optimal colorectal cancer screening in states' low-income, uninsured populations - The case of South Carolina
by: Van Der Steen, A., et al.
Published: (2015)
by: Van Der Steen, A., et al.
Published: (2015)
Cost-effectiveness analysis of a quantitative immunochemical test for colorectal cancer screening
by: Wilschut, J., et al.
Published: (2011)
by: Wilschut, J., et al.
Published: (2011)
Cost-effectiveness of one versus two sample faecal immunochemical testing for colorectal cancer screening
by: Goede, S., et al.
Published: (2013)
by: Goede, S., et al.
Published: (2013)
Colorectal cancer screening in Australia
by: Kuipers, E., et al.
Published: (2017)
by: Kuipers, E., et al.
Published: (2017)
European guidelines for quality assurance in colorectal cancer screening and diagnosis. First Edition Introduction
by: Lansdorp_Vogelaar, Iris, et al.
Published: (2012)
by: Lansdorp_Vogelaar, Iris, et al.
Published: (2012)
Validation of Models Used to Inform Colorectal Cancer Screening Guidelines
by: Rutter, C., et al.
Published: (2015)
by: Rutter, C., et al.
Published: (2015)
Cost-savings to medicare from pre-medicare colorectal cancer screening
by: Goede, S., et al.
Published: (2015)
by: Goede, S., et al.
Published: (2015)
State disparities in colorectal cancer rates: Contributions of risk factors, screening, and survival differences
by: Lansdorp_Vogelaar, Iris, et al.
Published: (2015)
by: Lansdorp_Vogelaar, Iris, et al.
Published: (2015)
Variation in adenoma detection rate and the lifetime benefits and cost of colorectal cancer screening: A microsimulation model
by: Meester, R., et al.
Published: (2015)
by: Meester, R., et al.
Published: (2015)
Public health impact of achieving 80% colorectal cancer screening rates in the United States by 2018
by: Meester, R., et al.
Published: (2015)
by: Meester, R., et al.
Published: (2015)
Harms, benefits and costs of fecal immunochemical testing versus guaiac fecal occult blood testing for colorectal cancer screening
by: Goede, S., et al.
Published: (2017)
by: Goede, S., et al.
Published: (2017)
Assessment of a cancer screening program
by: Rabeneck, L., et al.
Published: (2015)
by: Rabeneck, L., et al.
Published: (2015)
Consequences of Increasing Time to Colonoscopy Examination After Positive Result From Fecal Colorectal Cancer Screening Test
by: Meester, R., et al.
Published: (2016)
by: Meester, R., et al.
Published: (2016)
Development of new non-invasive tests for colorectal cancer screening: The relevance of information on adenoma detection
by: Haug, U., et al.
Published: (2015)
by: Haug, U., et al.
Published: (2015)
The Impact of Uncertainty in Barrett's Esophagus Progression Rates on Hypothetical Screening and Treatment Decisions
by: Kroep, S., et al.
Published: (2015)
by: Kroep, S., et al.
Published: (2015)
Cost-effectiveness of screening and treating Helicobacter pylori for gastric cancer prevention
by: Lansdorp_Vogelaar, Iris, et al.
Published: (2013)
by: Lansdorp_Vogelaar, Iris, et al.
Published: (2013)
Adherence to colorectal cancer screening: Four rounds of faecal immunochemical test-based screening
by: Van Der Vlugt, M., et al.
Published: (2017)
by: Van Der Vlugt, M., et al.
Published: (2017)
Cost Effectiveness of Screening Individuals With Cystic Fibrosis for Colorectal Cancer
by: Gini, A., et al.
Published: (2018)
by: Gini, A., et al.
Published: (2018)
Effects of Increasing Screening Age and Fecal Hemoglobin Cutoff Concentrations in a Colorectal Cancer Screening Program
by: Wieten, E., et al.
Published: (2016)
by: Wieten, E., et al.
Published: (2016)
Immunochemical faecal occult blood testing to screen for colorectal cancer: Can the screening interval be extended?
by: Haug, U., et al.
Published: (2016)
by: Haug, U., et al.
Published: (2016)
Sojourn time of preclinical colorectal cancer by sex and age: Estimates from the german national screening colonoscopy database
by: Brenner, H., et al.
Published: (2011)
by: Brenner, H., et al.
Published: (2011)
Nonbleeding adenomas: Evidence of systematic false-negative fecal immunochemical test results and their implications for screening effectiveness - A modeling study
by: Van Der Meulen, M., et al.
Published: (2016)
by: Van Der Meulen, M., et al.
Published: (2016)
Attendance and diagnostic yield of repeated two-sample faecal immunochemical test screening for colorectal cancer
by: Kapidzic, A., et al.
Published: (2015)
by: Kapidzic, A., et al.
Published: (2015)
Developing a score chart to improve risk stratification of patients with colorectal adenoma
by: Van Heijningen, E., et al.
Published: (2016)
by: Van Heijningen, E., et al.
Published: (2016)
Which blastocysts should be considered for genetic screening?
by: Yovich, John, et al.
Published: (2015)
by: Yovich, John, et al.
Published: (2015)
Estimation of benefits, burden, and harms of colorectal cancer screening strategies: Modeling study for the US preventive services Task Force
by: Knudsen, A., et al.
Published: (2016)
by: Knudsen, A., et al.
Published: (2016)
A systematic comparison of microsimulation models of colorectal cancer: The role of assumptions about adenoma progression
by: Kuntz, K., et al.
Published: (2011)
by: Kuntz, K., et al.
Published: (2011)
Second-Look Colonoscopies and the Impact on Capacity in FIT-Based Colorectal Cancer Screening
by: Grobbee, E., et al.
Published: (2015)
by: Grobbee, E., et al.
Published: (2015)
A randomised comparison of two faecal immunochemical tests in population-based colorectal cancer screening
by: Grobbee, E., et al.
Published: (2016)
by: Grobbee, E., et al.
Published: (2016)
Integrating personalised genomics into risk stratification models of population screening for colorectal cancer
by: Cenin, Dayna, et al.
Published: (2017)
by: Cenin, Dayna, et al.
Published: (2017)
Faecal immunochemical tests versus guaiac faecal occult blood tests: What clinicians and colorectal cancer screening programme organisers need to know
by: Tinmouth, J., et al.
Published: (2015)
by: Tinmouth, J., et al.
Published: (2015)
Similar Items
-
Personalizing Colonoscopy Screening for Elderly Individuals Based on Screening History, Cancer Risk, and Comorbidity Status Could Increase Cost Effectiveness
by: Van Hees, F., et al.
Published: (2015) -
How much colonoscopy screening should be recommended to individuals with various degrees of family history of colorectal cancer?
by: Wilschut, J., et al.
Published: (2011) -
Colorectal cancer deaths attributable to nonuse of screening in the United States
by: Meester, R., et al.
Published: (2015) -
The value of models in informing resource allocation in colorectal cancer screening: The case of the Netherlands
by: Van Hees, F., et al.
Published: (2015) -
Contribution of screening and survival differences to racial disparities in colorectal cancer rates
by: Lansdorp_Vogelaar, Iris, et al.
Published: (2012)